# Pfizer (PFE): value investors who own it | moatshark

6 value investors held Pfizer in their Q3 2026 13F, led by Kahn Brothers, Fairfax Financial Holdings, Fairholme Capital Management, Horizon Kinetics…

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Kahn Brothers | 1.8% | $11.2m | Trimmed -4.3% | 53 |
| Fairfax Financial Holdings | 0.9% | $25.1m | Added +5.3% | 23 |
| Fairholme Capital Management | 0.4% | $5.6m | New | 1 |
| Horizon Kinetics | 0.0% | $1.7m | Added +1.0% | 30 |
| Mairs & Power | 0.0% | $1.6m | Trimmed -5.8% | 53 |
| Dodge & Cox | 0.0% | $2.1m | Trimmed -0.8% | 53 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-08-12 | BOURLA ALBERT | Chairman & CEO | Bought | 38000 | $1.0m |
| 2026-08-05 | BLAYLOCK RONALD E | Director | Bought | 39231 | $999k |
| 2026-08-05 | Buckley Mortimer J | Director | Bought | 37632 | $960k |
| 2026-08-05 | DAMICO JENNIFER B. | SVP & Controller | Sold | 3278 | $83k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/pfe). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.